SG11202013194VA - Composition and method for opioid sparing - Google Patents

Composition and method for opioid sparing

Info

Publication number
SG11202013194VA
SG11202013194VA SG11202013194VA SG11202013194VA SG11202013194VA SG 11202013194V A SG11202013194V A SG 11202013194VA SG 11202013194V A SG11202013194V A SG 11202013194VA SG 11202013194V A SG11202013194V A SG 11202013194VA SG 11202013194V A SG11202013194V A SG 11202013194VA
Authority
SG
Singapore
Prior art keywords
composition
opioid sparing
sparing
opioid
Prior art date
Application number
SG11202013194VA
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of SG11202013194VA publication Critical patent/SG11202013194VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
SG11202013194VA 2018-07-03 2019-07-03 Composition and method for opioid sparing SG11202013194VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018100928A AU2018100928A4 (en) 2018-07-03 2018-07-03 Composition and method for opioid sparing
PCT/AU2019/050699 WO2020006598A1 (fr) 2018-07-03 2019-07-03 Composition et méthode pour un usage modéré des opioïdes

Publications (1)

Publication Number Publication Date
SG11202013194VA true SG11202013194VA (en) 2021-01-28

Family

ID=63079660

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202013194VA SG11202013194VA (en) 2018-07-03 2019-07-03 Composition and method for opioid sparing

Country Status (13)

Country Link
US (1) US20210290592A1 (fr)
EP (1) EP3817734A4 (fr)
KR (1) KR20210071941A (fr)
AU (2) AU2018100928A4 (fr)
BR (1) BR112020027070A2 (fr)
CA (1) CA3104741A1 (fr)
CL (1) CL2020003373A1 (fr)
CO (1) CO2021001057A2 (fr)
IL (1) IL279903A (fr)
MX (1) MX2021000023A (fr)
PE (1) PE20211586A1 (fr)
SG (1) SG11202013194VA (fr)
WO (1) WO2020006598A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3134108A1 (fr) * 2019-03-21 2020-09-24 ZYUS Life Sciences US Ltd. Cannabinoide et diminution graduelle d'une dose d'opioide facilitee par une application
JP2023529476A (ja) * 2020-06-12 2023-07-10 ゼリラ セラピューティクス オペレーションズ ピーティーワイ リミテッド 慢性疼痛を治療するための組成物及び方法
IL309776A (en) * 2021-07-01 2024-02-01 Ananda Scient Inc Methods of treating pain using cannabinoids
CA3241130A1 (fr) 2022-01-28 2023-08-03 Bastian BAASCH Procede de production d'un extrait de plante
AU2023214140A1 (en) 2022-01-31 2024-07-11 Vertanical GmbH Composition comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2965493C (fr) * 2014-10-21 2021-12-07 United Cannabis Corp. Extraits de cannabis et procedes de preparation et d'utilisation
EP3247402A4 (fr) * 2015-01-21 2018-08-08 Willinsky, Michael Composition et procédés pour améliorer la stabilité, le dosage, la pharmacodynamie et la durée de validité des cannabinoïdes endogènes, des cannabinoïdes végétaux et des cannabinoïdes synthétiques administrés par un inhalateur nasal
WO2018222923A1 (fr) * 2017-05-31 2018-12-06 Phytecs, Inc. Compositions pharmaceutiques comprenant du cannabidiol et du bêta-caryophyllène et leurs procédés d'utilisation
WO2019089558A1 (fr) * 2017-10-30 2019-05-09 Endocanna Health, Inc. Interfaces utilisateur graphiques permettant de déterminer des génotypes d'endocannabinoïde personnalisés et des recommandations associées

Also Published As

Publication number Publication date
EP3817734A1 (fr) 2021-05-12
CO2021001057A2 (es) 2021-06-30
CL2020003373A1 (es) 2021-08-13
AU2018100928A4 (en) 2018-08-09
AU2019297197A1 (en) 2021-01-28
CA3104741A1 (fr) 2020-01-09
EP3817734A4 (fr) 2022-03-16
PE20211586A1 (es) 2021-08-18
US20210290592A1 (en) 2021-09-23
IL279903A (en) 2021-03-01
KR20210071941A (ko) 2021-06-16
WO2020006598A1 (fr) 2020-01-09
MX2021000023A (es) 2021-05-27
BR112020027070A2 (pt) 2021-03-30

Similar Documents

Publication Publication Date Title
IL277079A (en) Cartirin preparations and methods of use
IL261511B (en) Smoking device and method for creating a spray
EP3528732A4 (fr) Procédé et dispositif pour l'administration améliorée d'une composition
EP3618896A4 (fr) Appareil d'injection et procédé d'utilisation
IL273664A (en) Fill-finish assemblies and related methods
GB2569404B (en) Positioning method and apparatus
IL279903A (en) Preparation and method for saving opioids
HK1251610A1 (zh) 用於抑制因子d的組合物和方法
IL263439A (en) Composition and method for reducing neutropenia
SG11202003790PA (en) Composition and method
GB201905559D0 (en) Composition and method
ZA201806655B (en) Abalone farming apparatus and methods
GB201909542D0 (en) Composition and method
EP3363163A4 (fr) Procédé et appareil pour réserver des interactions d'agent à temps d'attente nul
ZA202000850B (en) Herbicidal composition and method
EP3234625A4 (fr) Procédé et appareil d'estimation de temps d'initiation de forme d'onde
EP3209397A4 (fr) Procédé et appareil permettant d'activer et de distribuer des cartes à gratter numériques
GB201718137D0 (en) Barrier apparatus and method of use thereof
GB201700116D0 (en) Method and composition
SG11201705265RA (en) Composition for forming underlayer and method for forming underlayer therewith
SG11201605960WA (en) Method and apparatus for playing behavior event
ZA201904187B (en) Method and composition
ZA201903032B (en) Nail plater apparatus and related methods
GB201818328D0 (en) Method and composition
GB201817000D0 (en) Method and composition